Pirker R - Search Results

1

Advanced non-small-cell lung cancer: adjunctive interferon gamma in induction and maintenance therapy.

Prior C, Oroszy S, Oberaigner W, Ambrosch G, Mohn-Staudner A, Pfeifer W, Pirker R, Huber H. Prior C, et al. Among authors: pirker r. J Cancer Res Clin Oncol. 1999;125(1):42-6. doi: 10.1007/s004320050240. J Cancer Res Clin Oncol. 1999. PMID: 10037276 Clinical Trial.

2

Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.

Scheithauer W, Kornek G, Haider K, Kwasny W, Schenk T, Pirker R, Depisch D. Scheithauer W, et al. Among authors: pirker r. Breast Cancer Res Treat. 1993;26(1):49-53. doi: 10.1007/BF00682699. Breast Cancer Res Treat. 1993. PMID: 8400323 Clinical Trial.

3

Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC).

Pirker R, Krajnik G, Zöchbauer S, Malayeri R, Kneussl M, Huber H. Pirker R, et al. Ann Oncol. 1995 Oct;6(8):833-5. doi: 10.1093/oxfordjournals.annonc.a059324. Ann Oncol. 1995. PMID: 8589023 Free article. Clinical Trial.

4

Dexverapamil as resistance modifier in acute myeloid leukaemia.

Pirker R, Zöchbauer S, Kupper H, Lassmann A, Gsur A, Frass M, Krajnik G, Knöbl P, Lechner K. Pirker R, et al. J Cancer Res Clin Oncol. 1995;121 Suppl 3:R21-4. doi: 10.1007/BF02351067. J Cancer Res Clin Oncol. 1995. PMID: 8698738

5

Phase II trial of gemcitabine in advanced non-small-cell lung cancer.

Malayeri R, Ulsperger E, Baumgartner G, Forstner B, Aigner K, Hubner M, Kummer F, Krajnik G, Zöchbauer S, Krejcy K, Huber H, Pirker R. Malayeri R, et al. Among authors: pirker r. Wien Klin Wochenschr. 1997 Sep 19;109(17):688-91. Wien Klin Wochenschr. 1997. PMID: 9331958 Clinical Trial.

6

Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy.

Berger T, Malayeri R, Doppelbauer A, Krajnik G, Huber H, Auff E, Pirker R. Berger T, et al. Among authors: pirker r. Eur J Cancer. 1997 Aug;33(9):1393-9. doi: 10.1016/s0959-8049(97)00103-2. Eur J Cancer. 1997. PMID: 9337680 Clinical Trial.

7

MDR1 RNA transcripts do not indicate long-term prognosis in colorectal carcinomas.

Zöchbauer S, Wallner J, Haider K, Depisch D, Huber H, Pirker R. Zöchbauer S, et al. Among authors: pirker r. Eur J Cancer. 1997 Aug;33(9):1516-8. doi: 10.1016/s0959-8049(97)00139-1. Eur J Cancer. 1997. PMID: 9337699

8

Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.

Filipits M, Suchomel RW, Zöchbauer S, Brunner R, Lechner K, Pirker R. Filipits M, et al. Among authors: pirker r. Clin Cancer Res. 1997 Aug;3(8):1419-25. Clin Cancer Res. 1997. PMID: 9815827 Clinical Trial.

9

Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial.

Krajnik G, Wein W, Greil R, Marhold F, Mohn-Staudner A, Kummer F, Malayeri R, Zöchbauer-Müller S, Huber H, Pirker R. Krajnik G, et al. Among authors: pirker r. Eur J Cancer. 1998 Nov;34(12):1977-80. doi: 10.1016/s0959-8049(98)00235-4. Eur J Cancer. 1998. PMID: 10023326 Clinical Trial.

10

The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer.

Kandioler-Eckersberger D, Kappel S, Mittlböck M, Dekan G, Ludwig C, Janschek E, Pirker R, Wolner E, Eckersberger F. Kandioler-Eckersberger D, et al. Among authors: pirker r. J Thorac Cardiovasc Surg. 1999 Apr;117(4):744-50. doi: 10.1016/S0022-5223(99)70295-3. J Thorac Cardiovasc Surg. 1999. PMID: 10096970 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters